Literature DB >> 11818093

Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions.

C A Sun1, J F Liu, D M Wu, S Nieh, C P Yu, T Y Chu.   

Abstract

OBJECTIVES: This case-control study was conducted to investigate the role of viral load of high-risk human papillomaviruses (HPVs) in the development of cervical squamous intraepithelial lesions (SILs) and invasive cancers.
METHODS: A total of 30 female cases who had histological evidence of low-grade SIL (n=10) or high-grade SIL and above (n=20) were identified as the case group at the Tri-Service General Hospital, Taipei between September 1998 and March 1999. In addition, 80 female controls who had normal cervical cytology were enrolled and individually matched on age (+/-5 years) and date of recruitment to each case. Cervical swabs collected from study subjects were tested for the positivity and viral load of high-risk HPVs by Hybrid Capture II assay. Additionally, subjects completed a risk factor questionnaire.
RESULTS: Among sex behavioral factors studied, younger age at first intercourse was associated with a significantly elevated risk of cervical SIL and invasive cancers. With respect to HPV infection, high-risk HPV DNA was present in 70% (21/30) of case and 21% (17/80) of control subjects, resulting in an odds ratio (OR) of 6.6 [95% confidence interval (C.I.)=2.6-17.0]. Moreover, women who had a high viral load were at significantly greater risk for cervical SIL and invasive cancers than those who were infected with a low viral load (OR=18.0, 95% C.I.=3.0-108.5).
CONCLUSIONS: Among the variables tested, infection with a high viral load of high-risk HPVs is the strongest determinant for cervical SIL and cervical cancers in Taiwan.

Entities:  

Mesh:

Year:  2002        PMID: 11818093     DOI: 10.1016/s0020-7292(01)00529-x

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  11 in total

1.  Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology.

Authors:  Andreas Clad; Miriam Reuschenbach; Johanna Weinschenk; Ruth Grote; Janina Rahmsdorf; Nikolaus Freudenberg
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

Review 2.  Clinical significance of human papilloma virus infection in the cervical lesions.

Authors:  Shuang Li; Yu-Han Meng; Hu Ting; Jian Shen; Ding Ma
Journal:  Front Med China       Date:  2010-07-16

3.  Kinetics of DNA load predict HPV 16 viral clearance.

Authors:  M Marks; P E Gravitt; U Utaipat; S B Gupta; K Liaw; E Kim; A Tadesse; C Phongnarisorn; V Wootipoom; P Yuenyao; C Vipupinyo; S Rugpao; S Sriplienchan; D D Celentano
Journal:  J Clin Virol       Date:  2011-03-09       Impact factor: 3.168

4.  Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.

Authors:  Rachel L Winer; Tiffany G Harris; Long Fu Xi; Kathrin U Jansen; James P Hughes; Qinghua Feng; Carolee Welebob; Jesse Ho; Shu-Kuang Lee; Joseph J Carter; Denise A Galloway; Nancy B Kiviat; Laura A Koutsky
Journal:  J Med Virol       Date:  2009-04       Impact factor: 2.327

5.  Prevalence and predictors of high-risk human papillomavirus infection in a population-based sample of women in rural Uganda.

Authors:  Stephen Asiimwe; Christopher C Whalen; Daniel J Tisch; Elioda Tumwesigye; Ajay K Sethi
Journal:  Int J STD AIDS       Date:  2008-09       Impact factor: 1.359

6.  Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue.

Authors:  Karin Biedermann; Nadia Dandachi; Maria Trattner; Georgia Vogl; Hildegard Doppelmayr; Elena Moré; Alfons Staudach; Otto Dietze; Cornelia Hauser-Kronberger
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

7.  High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study.

Authors:  Martin Dreilich; Michael Bergqvist; Martin Moberg; Daniel Brattström; Inger Gustavsson; Stefan Bergström; Alkwin Wanders; Patrik Hesselius; Gunnar Wagenius; Ulf Gyllensten
Journal:  BMC Cancer       Date:  2006-04-18       Impact factor: 4.430

8.  Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN).

Authors:  S Andersson; H Safari; M Mints; I Lewensohn-Fuchs; U Gyllensten; B Johansson
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

9.  High viral loads of human papillomavirus predict risk of invasive cervical carcinoma.

Authors:  M Moberg; I Gustavsson; E Wilander; U Gyllensten
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

10.  Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test.

Authors:  Mohamed A Youssef; Lobna Abdelsalam; Reem Abdelhameed Harfoush; Iman Mamdouh Talaat; Eman Elkattan; Abeer Mohey; Rana M A Abdella; Marwa Salah Farhan; Hany Ahmed Foad; Abeer Mostafa Elsayed; Naglaa A Elkinaai; Doaa Ghaith; Mohamed Elsayed Rashed; Mohamed Abd-El Ghafar; Yasser Khamis; Ahmed N Hosni
Journal:  Infect Agent Cancer       Date:  2016-02-17       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.